share_log

李嘉诚旗下长江生命科技港股涨近30%,AI助力癌症疫苗研究获进展,公司将在AACR年会展示癌症疫苗研究数据。

The Hong Kong stock of Li Ka-shing's Changjiang Life Science and Technology rose nearly 30%. AI helped advance cancer vaccine research. The company will present cancer vaccine research data at the AACR annual meeting.

Zhitong Finance ·  Apr 8 13:27
The Hong Kong stock of Li Ka-shing's Changjiang Life Science and Technology rose nearly 30%. AI helped advance cancer vaccine research. The company will present cancer vaccine research data at the AACR annual meeting.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment